As of 2026-04-02, 国药集团北京华邈药业有限公司's data on the DeepSeek platform in the 医药制造 category shows: The overall mention rate is 0.00%, below the industry average by 9.4 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 国药集团北京华邈药业有限公司's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
国药集团北京华邈药业有限公司's Mention Rate is 0.00%, lower than 0.6% of competitors
国药集团北京华邈药业有限公司's First Mention is 0.00%, lower than 0.9% of competitors
国药集团北京华邈药业有限公司's Preferred Rate is 0.00%, lower than 100.0% of competitors
国药集团北京华邈药业有限公司's Positive Rate is 0.00%, lower than 8.9% of competitors
国药集团北京华邈药业有限公司's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 百百济神州 | 67.14% | 11.43% | 0% | 58.57% | 1.43% | View Details |
| 中中国生物制药 | 42.86% | 0% | 0% | 34.29% | 0% | View Details |
| 艾艾伯维 | 34.29% | 0% | 0% | 32.86% | 1.43% | View Details |
| 阿阿斯利康 | 32.86% | 0% | 0% | 30% | 0% | View Details |
| 诺诺和诺德 | 32.86% | 0% | 0% | 28.57% | 7.14% | View Details |
| 信信达生物 | 30% | 0% | 0% | 20% | 0% | View Details |
| 国国药集团北京华邈药业有限公司 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
